The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differences in clinical outcomes in young-onset colorectal cancer based on ethnicity in an NCI designated comprehensive cancer center.
 
Benjamin David Fangman
No Relationships to Disclose
 
Stephen Haff
No Relationships to Disclose
 
Shannon Scielzo
No Relationships to Disclose
 
Aravind Sanjeevaiah
Travel, Accommodations, Expenses - NanoCarrier
 
Udit N. Verma
No Relationships to Disclose
 
John Vernon Cox
Employment - University of Texas Southwestern Medical Center - Simmons Cancer Center
Leadership - Parkland Health System
Stock and Other Ownership Interests - Amgen; Medfusion; Merck; Pfizer
Honoraria - American College of Physicians; Association of Community Cancer Centers (ACCC); National Academies of Science Engineering Medicine; NCCN
Research Funding - US Oncology
Travel, Accommodations, Expenses - American College of Physicians; Association of Community Cancer Centers (ACCC)
Other Relationship - American Society of Clinical Oncology; Mary Crowley Research Center, Dallas Texas; Texas Oncology
 
Radhika Kainthla
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Boston Biomedical; Celgene; Genentech/Roche; Guardant Health; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Syed Mohammad Ali Kazmi
No Relationships to Disclose